We are live on ! Find out more
TCM

Tamarack Capital Management Portfolio holdings

AUM $840M
1-Year Est. Return 19.47%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+19.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$422M
AUM Growth
+$44.6M
Cap. Flow
+$2.83M
Cap. Flow %
0.67%
Top 10 Hldgs %
69.03%
Holding
44
New
12
Increased
9
Reduced
7
Closed
15

Top Buys

Rank Stock Value
1
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$14M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$13.7M
3
WELL icon
Welltower
WELL
+$9.81M
4
INSY
Insys Therapeutics, Inc.
INSY
+$9.78M
5
NXTM
NxStage Medical Inc.
NXTM
+$9.73M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$23.2M
2
PCRX icon
Pacira BioSciences
PCRX
+$15.8M
3
VPHM
VIROPHARMA INC
VPHM
+$13.7M
4
MDAS
MEDASSETS INC COM STK (DE)
MDAS
+$11.2M
5
NTUS
Natus Medical Inc
NTUS
+$8.35M

Sector Composition

Rank Sector Weight
1 Healthcare 43.34%
2 Real Estate 4.02%
3 Technology 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPCH icon
26
Option Care Health
OPCH
$3.55B
$3.7M 0.88%
+125,000
New +$3.53M
CNMD icon
27
CONMED
CNMD
$1.55B
$2.39M 0.57%
56,337
-21,056
-27% -$800K
WINT
28
DELISTED
Windtree Therapeutics Inc
WINT
$554K 0.13%
+17,575
New +$550K
OSUR icon
29
OraSure Technologies
OSUR
$286M
$377K 0.09%
+59,981
New +$377K
BRKR icon
30
Bruker
BRKR
$9.79B
– –
-175,000
Closed -$3.61M
CHE icon
31
Chemed
CHE
$7.07B
– –
-37,000
Closed -$2.65M
DGX icon
32
Quest Diagnostics
DGX
$25.6B
– –
-375,000
Closed -$23.2M
EW icon
33
Edwards Lifesciences
EW
$51.1B
– –
-673,200
Closed -$7.81M
HSTM icon
34
HealthStream
HSTM
$828M
– –
-76,423
Closed -$2.9M
LAB icon
35
Standard BioTools
LAB
$339M
– –
-43,974
Closed -$965K
LH icon
36
Labcorp
LH
$24.9B
– –
-46,560
Closed -$3.97M
PRGO icon
37
Perrigo
PRGO
$1.48B
– –
-66,000
Closed -$8.14M
TEVA icon
38
CALL
Teva Pharmaceuticals
TEVA
$40.2B
– –
-270,000
Closed -$10.2M
XLV icon
39
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
– –
-200,000
Closed -$10.1M
NTUS
40
DELISTED
Natus Medical Inc
NTUS
– –
-589,080
Closed -$8.35M
MDAS
41
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
– –
-440,000
Closed -$11.2M
GTIV
42
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
– –
-157,525
Closed -$1.9M
VPHM
43
DELISTED
VIROPHARMA INC
VPHM
– –
-350,000
Closed -$13.7M
SLTM
44
DELISTED
SOLTA MED INC (DE)
SLTM
– –
-1,500,000
Closed -$3.1M
1
2

Similar funds

RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return
CWA
Constellation Wealth Advisors New York $903M AUM 2.38% 1-Year Est. Return
GHF
Good Harbor Financial Barrington, Illinois $916M AUM 5.96% 1-Year Est. Return
F
FutureAdvisor San Francisco, California $617M AUM 6.57% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
BMCMI
Bryn Mawr Capital Management Inc Bryn Mawr, Pennsylvania $577M AUM 6.5% 1-Year Est. Return
GACM
Green Arrow Capital Management New York $535M AUM 14.21% 1-Year Est. Return
AH
Achievement Holdings Chicago, Illinois $1.2B AUM 9.2% 1-Year Est. Return

Tamarack Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Tamarack Capital Management held 44 positions worth $422M, up 12% from $378M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Tamarack Capital Management's Q4 2013 filing shows 12 new, 9 increased, 7 reduced and 15 closed positions. Its largest new stake was Welltower: 165,000 shares worth $8.84M. The largest sale was Quest Diagnostics, an estimated $23.2M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 46% a quarter earlier, followed by Real Estate and Technology.

  • Tamarack Capital Management's largest Q4 2013 buy was Welltower: 165,000 shares worth $8.84M.
  • Tamarack Capital Management added most to VOLCANO CORPORATION COM STK in Q4 2013, an estimated $14M increase.
  • Tamarack Capital Management's biggest Q4 2013 reduction was Pacira BioSciences, cutting an estimated $15.8M.
  • Tamarack Capital Management fully exited Quest Diagnostics in Q4 2013, selling an estimated $23.2M.
  • Tamarack Capital Management's ten largest holdings make up 69% of its $422M portfolio in Q4 2013.
  • Tamarack Capital Management opened 12 new positions and closed 15 in Q4 2013.
  • Tamarack Capital Management's portfolio value rose 12% quarter-over-quarter to $422M.

Based on Tamarack Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.